▁Chron 10.375
ic 5.49609375
▁infl 13.453125
amm 1.3642578125
ation 0.78857421875
▁is 4.19921875
▁a 2.185546875
▁persistent 5.8125
▁condition 5.8203125
▁that 3.220703125
▁affect 5.125
s 0.289306640625
▁a 2.65625
▁wide 5.9609375
▁range 2.59375
▁of 0.156982421875
▁individuals 5.0859375
▁with 3.20703125
▁various 4.109375
▁medical 4.6875
▁conditions 2.048828125
, 2.189453125
▁including 3.115234375
▁end 7.0078125
- 1.580078125
stage 0.40234375
▁ren 3.8984375
al 0.04150390625
▁disease 3.275390625
▁( 3.5546875
ES 1.6845703125
R 0.1864013671875
D 0.779296875
) 1.189453125
▁and 1.763671875
▁those 8.171875
▁under 5.8671875
going 3.33984375
▁d 6.79296875
ial 0.37890625
ysis 0.036376953125
▁treatment 6.35546875
. 2.759765625
▁The 2.712890625
▁article 7.78125
▁" 4.07421875
Chr 4.3984375
onic 0.14990234375
▁In 2.2578125
fl 0.027801513671875
amm 0.0386962890625
ation 0.01751708984375
▁in 3.36328125
▁End 2.42578125
- 0.32958984375
Stage 0.30078125
▁Ren 0.273193359375
al 0.026641845703125
▁D 0.0789794921875
ise 0.003997802734375
ase 0.0134735107421875
▁and 2.65625
▁D 2.671875
ial 0.00533294677734375
ysis 0.001834869384765625
" 3.1953125
▁sh 8.5859375
eds 0.047271728515625
▁light 0.2220458984375
▁on 0.06329345703125
▁the 0.7939453125
▁leading 7.4296875
▁causes 1.0185546875
▁of 0.2216796875
▁chron 1.7392578125
ic 0.005237579345703125
▁infl 0.10552978515625
amm 0.0026988983154296875
ation 0.007171630859375
▁in 0.9228515625
▁individuals 4.375
▁with 0.7158203125
▁E 2.55859375
SR 0.003948211669921875
D 0.007503509521484375
, 1.79296875
▁the 3.4609375
▁impact 4.09375
▁of 0.44677734375
▁this 3.75
▁disease 3.609375
▁on 0.55419921875
▁clin 7.03515625
ical 0.138427734375
▁out 1.09765625
comes 0.0038394927978515625
, 0.55078125
▁and 0.27880859375
▁the 0.876953125
▁role 3.1484375
▁of 0.240234375
▁middle 11.640625
▁mole 2.84375
cules 0.312255859375
▁in 0.6083984375
▁the 1.4501953125
▁development 2.876953125
▁of 0.185302734375
▁path 8.1953125
ology 1.447265625
. 0.8603515625
▁Furthermore 4.78515625
, 0.005828857421875
▁it 2.287109375
▁expl 4.2109375
ores 0.0167388916015625
▁the 0.427001953125
▁latest 4.85546875
▁break 4.05859375
through 0.006053924560546875
s 0.1142578125
▁and 2.060546875
▁research 3.736328125
▁in 2.072265625
▁d 2.78515625
ial 0.0020580291748046875
ysis 0.007175445556640625
, 2.505859375
▁which 3.275390625
▁aim 5.45703125
▁to 0.1448974609375
▁stabil 6.86328125
ize 0.034454345703125
▁this 5.12109375
▁condition 2.310546875
. 1.443359375
<0x0A> 0.98388671875
The 1.7314453125
▁article 1.298828125
▁ident 6.8984375
ifies 0.0007557868957519531
▁several 3.4296875
▁leading 3.076171875
▁causes 0.14697265625
▁of 0.06341552734375
▁chron 0.1585693359375
ic 0.0005278587341308594
▁infl 0.00395965576171875
amm 0.002506256103515625
ation 0.0002827644348144531
▁in 0.275146484375
▁individuals 0.455810546875
▁with 0.037841796875
▁E 0.24169921875
SR 0.0010652542114257812
D 0.000606536865234375
. 1.9267578125
▁One 3.50390625
▁of 0.5419921875
▁the 0.3642578125
▁primary 4.109375
▁causes 0.62353515625
▁is 0.83203125
▁the 1.1953125
▁bu 5.37890625
il 0.0002808570861816406
dup 0.0001652240753173828
▁of 0.0191802978515625
▁middle 9.2578125
▁mole 0.093994140625
cules 0.00986480712890625
▁in 1.1494140625
▁the 0.2509765625
▁blood 2.17578125
stream 0.497314453125
. 1.0380859375
▁These 1.5009765625
▁middle 2.404296875
▁mole 0.007579803466796875
cules 0.003162384033203125
▁are 1.3583984375
▁the 3.353515625
▁by 3.427734375
products 0.5390625
▁of 0.03143310546875
▁the 1.2841796875
▁incomplete 7.6171875
▁met 2.357421875
abol 0.0008196830749511719
ism 0.166748046875
▁of 0.09808349609375
▁larger 7.04296875
▁mole 0.350341796875
cules 0.01751708984375
▁in 2.205078125
▁the 0.1175537109375
▁body 0.6884765625
. 0.439453125
▁In 2.90234375
▁individuals 3.349609375
▁with 0.058868408203125
▁E 0.35693359375
SR 0.0013055801391601562
D 0.00041604042053222656
, 0.038604736328125
▁the 1.333984375
▁kid 4.23046875
ne 0.13525390625
ys 3.5762786865234375e-06
' 4.41796875
▁in 2.658203125
ability 0.036956787109375
▁to 0.0013790130615234375
▁filter 1.9482421875
▁these 1.486328125
▁middle 1.9169921875
▁mole 0.0023593902587890625
cules 0.004302978515625
▁effectively 3.921875
▁leads 0.966796875
▁to 0.00676727294921875
▁their 3.58984375
▁accum 0.401123046875
ulation 0.0008120536804199219
, 2.826171875
▁causing 2.677734375
▁chron 1.0986328125
ic 0.00086212158203125
▁infl 0.010040283203125
amm 0.00295257568359375
ation 0.00029015541076660156
. 0.3330078125
▁Moreover 4.90234375
, 0.00020003318786621094
▁ox 7.171875
id 0.0087890625
ative 0.07818603515625
▁stress 0.10614013671875
, 1.78515625
▁which 1.4111328125
▁is 0.51953125
▁an 3.00390625
▁im 1.771484375
bal 0.0019502639770507812
ance 0.0162506103515625
▁between 0.435791015625
▁the 0.6220703125
▁production 0.6416015625
▁of 0.5537109375
▁harm 4.08203125
ful 0.0001647472381591797
▁free 0.49658203125
▁radical 0.00316619873046875
s 0.011962890625
▁and 0.053863525390625
▁the 0.438720703125
▁body 1.3974609375
' 0.0006265640258789062
s 0.00039768218994140625
▁ability 0.51806640625
▁to 0.00034236907958984375
▁neutral 1.392578125
ize 0.003360748291015625
▁them 0.1982421875
, 0.0307464599609375
▁also 1.4794921875
▁cont 0.59033203125
ributes 3.6954879760742188e-06
▁to 0.0305328369140625
▁chron 0.68505859375
ic 0.00025725364685058594
▁infl 0.0017004013061523438
amm 0.002277374267578125
ation 0.0001957416534423828
▁in 0.9677734375
▁E 1.087890625
SR 0.0020198822021484375
D 0.0006809234619140625
▁patients 0.56787109375
. 0.0219879150390625
<0x0A> 0.7294921875
The 1.1318359375
▁impact 4.15625
▁of 0.01175689697265625
▁chron 0.409912109375
ic 0.00028228759765625
▁infl 0.0019388198852539062
amm 0.0012063980102539062
ation 2.6226043701171875e-05
▁on 0.50830078125
▁clin 0.07891845703125
ical 0.00012886524200439453
▁out 0.0089111328125
comes 2.562999725341797e-05
▁is 1.4462890625
▁substantial 3.767578125
▁in 3.1484375
▁individuals 0.93603515625
▁with 0.0139617919921875
▁end 3.333984375
- 0.00952911376953125
stage 0.0014562606811523438
▁ren 0.045501708984375
al 1.2636184692382812e-05
▁failure 4.7578125
. 0.489501953125
▁Studies 4.265625
▁have 0.260009765625
▁shown 0.304443359375
▁that 0.0253448486328125
▁chron 0.57470703125
ic 0.0031833648681640625
▁infl 0.00685882568359375
amm 0.004688262939453125
ation 4.279613494873047e-05
▁is 1.447265625
▁associated 0.79833984375
▁with 0.0007414817810058594
▁increased 2.029296875
▁card 3.541015625
i 0.055328369140625
ov 0.0020885467529296875
asc 5.805492401123047e-05
ular 2.0265579223632812e-06
▁mort 1.4150390625
ality 0.0002453327178955078
, 0.67626953125
▁imm 7.01953125
une 0.56298828125
▁d 1.4384765625
ys 0.0035343170166015625
function 0.54150390625
, 0.02386474609375
▁and 0.458984375
▁mal 6.6953125
nut 0.0709228515625
r 4.1365623474121094e-05
ition 0.0010423660278320312
▁in 1.2861328125
▁these 1.916015625
▁patients 0.3330078125
. 0.0594482421875
▁High 6.85546875
▁levels 0.6767578125
▁of 0.0005750656127929688
▁infl 1.04296875
am 1.923828125
mat 0.0003764629364013672
ory 0.0003719329833984375
▁markers 0.572265625
▁like 4.16796875
▁C 0.56201171875
- 0.05694580078125
re 0.0094146728515625
active 0.0007505416870117188
▁protein 0.0062408447265625
▁have 3.046875
▁been 0.7333984375
▁found 2.07421875
▁to 0.1546630859375
▁be 0.416015625
▁independent 5.953125
▁predict 0.57568359375
ors 0.00969696044921875
▁of 0.02435302734375
▁poor 2.54296875
▁clin 0.90771484375
ical 0.00032782554626464844
▁out 0.0675048828125
comes 3.266334533691406e-05
▁in 0.4169921875
▁E 1.1044921875
SR 0.0007333755493164062
D 0.00165557861328125
▁individuals 5.3359375
. 0.228759765625
▁Furthermore 1.83203125
, 0.00015604496002197266
▁chron 0.76611328125
ic 0.002552032470703125
▁infl 0.007587432861328125
amm 0.006893157958984375
ation 5.066394805908203e-05
▁also 3.326171875
▁plays 2.60546875
▁a 0.10577392578125
▁cru 3.41015625
cial 0.00018095970153808594
▁role 0.004993438720703125
▁in 0.002155303955078125
▁the 0.2626953125
▁path 3.49609375
ogen 0.39111328125
esis 0.0020503997802734375
▁of 0.050750732421875
▁card 4.42578125
i 0.1153564453125
ov 0.01043701171875
asc 0.00011396408081054688
ular 2.86102294921875e-06
▁dise 1.953125
ases 0.00011146068572998047
, 1.3359375
▁which 2.3359375
▁are 1.009765625
▁the 1.4462890625
▁leading 0.21728515625
▁cause 0.386474609375
▁of 0.0015916824340820312
▁death 0.40380859375
▁among 1.90234375
▁E 1.2412109375
SR 0.0007491111755371094
D 0.0012483596801757812
▁patients 0.05511474609375
. 0.07305908203125
<0x0A> 0.491943359375
Middle 4.0546875
▁mole 0.023712158203125
cules 0.01312255859375
, 2.828125
▁particularly 3.755859375
▁ 6.87890625
β 2.23828125
2 1.7138671875
- 0.34130859375
m 0.374267578125
icro 0.0025196075439453125
glob 0.0009336471557617188
ul 0.00408935546875
in 0.007625579833984375
, 0.49462890625
▁have 1.9072265625
▁been 0.289306640625
▁imp 2.154296875
licated 0.0007634162902832031
▁in 0.185302734375
▁the 0.16552734375
▁development 0.4189453125
▁of 0.0667724609375
▁path 3.4609375
ology 0.07183837890625
▁associated 3.8203125
▁with 0.0019464492797851562
▁E 0.95068359375
SR 0.0007824897766113281
D 0.0003063678741455078
. 0.1922607421875
▁The 2.39453125
▁article 7.859375
▁highlight 3.169921875
s 0.0032825469970703125
▁that 1.54296875
▁ 1.3984375
β 0.003936767578125
2 0.0129852294921875
- 0.00882720947265625
m 0.002658843994140625
icro 0.0005078315734863281
glob 0.0012874603271484375
ul 0.00042319297790527344
in 0.0028324127197265625
▁accum 2.9921875
ul 1.0595703125
ates 7.915496826171875e-05
▁in 0.265625
▁the 0.293212890625
▁blood 0.98583984375
▁of 3.76953125
▁individuals 1.1875
▁with 0.0189971923828125
▁E 0.1751708984375
SR 0.0003857612609863281
D 0.0002541542053222656
▁due 2.013671875
▁to 0.0012006759643554688
▁the 1.037109375
▁in 1.517578125
ade 2.478515625
qu 0.001537322998046875
ate 0.0291900634765625
▁clear 3.2578125
ance 0.006847381591796875
▁by 3.333984375
▁the 0.053070068359375
▁kid 0.03680419921875
ne 0.069091796875
ys 2.384185791015625e-06
. 0.22802734375
▁This 1.333984375
▁leads 2.58984375
▁to 0.0007433891296386719
▁the 1.2080078125
▁de 3.984375
position 0.0226593017578125
▁of 0.014556884765625
▁ 0.7333984375
β 0.0007886886596679688
2 0.01007080078125
- 0.005954742431640625
m 0.0016031265258789062
icro 0.00017070770263671875
glob 0.0045623779296875
ul 0.0003039836883544922
in 0.0008420944213867188
▁in 0.350830078125
▁various 1.46484375
▁t 0.66748046875
issues 0.0088958740234375
, 0.71337890625
▁including 0.59228515625
▁the 0.22900390625
▁joint 5.09765625
s 0.06585693359375
, 0.1453857421875
▁leading 8.8359375
▁to 0.0004329681396484375
▁the 1.7763671875
▁development 0.392822265625
▁of 0.006160736083984375
▁d 7.90234375
ial 1.0615234375
ysis 0.011566162109375
- 0.136962890625
related 1.0234375
▁am 4.86328125
y 0.00936126708984375
lo 0.0028076171875
idos 0.428955078125
is 0.010650634765625
. 0.52978515625
▁This 3.814453125
▁condition 1.25
▁causes 3.482421875
▁joint 3.728515625
▁pain 0.66552734375
, 0.50537109375
▁st 2.14453125
iff 0.00043845176696777344
ness 0.00850677490234375
, 0.00724029541015625
▁and 0.1800537109375
▁sw 1.3388671875
elling 0.00604248046875
, 0.64501953125
▁further 7.09765625
▁comprom 4.18359375
ising 0.0015783309936523438
▁the 0.32373046875
▁quality 0.69384765625
▁of 0.0037822723388671875
▁life 0.01131439208984375
▁of 0.363037109375
▁E 1.6494140625
SR 0.0004229545593261719
D 0.0004398822784423828
▁patients 0.0259246826171875
. 0.01306915283203125
<0x0A> 0.3037109375
However 6.73046875
, 0.0001577138900756836
▁recent 2.01953125
▁break 2.83203125
through 0.00019657611846923828
s 0.0161590576171875
▁and 1.3779296875
▁research 0.08709716796875
▁in 0.6630859375
▁d 0.046722412109375
ial 1.1205673217773438e-05
ysis 0.00037407875061035156
▁have 0.51025390625
▁aim 5.31640625
ed 0.0016269683837890625
▁to 0.10443115234375
▁stabil 0.290283203125
ize 0.002468109130859375
▁the 2.197265625
▁condition 0.475341796875
▁and 1.7109375
▁alle 5.17578125
vi 0.0001741647720336914
ate 0.0010614395141601562
▁chron 3.12890625
ic 0.00016295909881591797
▁infl 0.00572967529296875
amm 0.0052642822265625
ation 0.00011897087097167969
▁in 0.77294921875
▁E 0.464599609375
SR 0.00052642822265625
D 0.00037860870361328125
▁patients 0.122802734375
. 0.048583984375
▁Hem 8.8828125
odia 3.640625
fil 0.0007319450378417969
tr 0.0006160736083984375
ation 0.00047969818115234375
, 0.7236328125
▁a 1.3056640625
▁modified 5.44140625
▁form 0.87060546875
▁of 0.0016908645629882812
▁conventional 4.81640625
▁d 1.9921875
ial 4.0531158447265625e-06
ysis 0.00336456298828125
, 0.3212890625
▁has 0.71826171875
▁shown 2.171875
▁prom 1.3173828125
ising 2.086162567138672e-05
▁results 0.09033203125
▁in 0.09417724609375
▁reducing 1.15234375
▁chron 2.779296875
ic 0.00038623809814453125
▁infl 0.00351715087890625
amm 0.005523681640625
ation 7.11679458618164e-05
▁and 0.93603515625
▁impro 0.841796875
ving 4.2319297790527344e-05
▁clin 0.61669921875
ical 0.00020647048950195312
▁out 0.011810302734375
comes 5.8770179748535156e-05
. 1.666015625
▁This 2.396484375
▁technique 1.9287109375
▁effectively 6.73828125
▁removes 0.79638671875
▁middle 2.533203125
▁mole 0.003986358642578125
cules 0.00421142578125
▁from 0.470703125
▁the 0.0201873779296875
▁blood 0.11163330078125
stream 0.4873046875
, 1.2265625
▁thereby 1.4501953125
▁mit 5.484375
ig 7.3909759521484375e-06
ating 4.7326087951660156e-05
▁the 0.53173828125
▁infl 3.513671875
am 0.180419921875
mat 9.381771087646484e-05
ory 2.1696090698242188e-05
▁response 0.72412109375
. 1.3125
▁Additionally 2.029296875
, 9.751319885253906e-05
▁adv 6.84375
ances 0.7451171875
▁in 0.0071258544921875
▁d 2.083984375
ial 0.00021791458129882812
y 5.48046875
zer 0.052093505859375
▁memb 3.201171875
rane 0.71337890625
▁technology 0.615234375
▁have 0.2467041015625
▁allowed 2.615234375
▁for 0.57421875
▁better 5.0078125
▁removal 3.716796875
▁of 0.03338623046875
▁middle 0.5322265625
▁mole 0.00153350830078125
cules 0.0027866363525390625
, 1.2822265625
▁leading 2.3046875
▁to 0.00041747093200683594
▁a 1.4951171875
▁reduction 0.8896484375
▁in 0.0205230712890625
▁chron 2.03125
ic 0.0002505779266357422
▁infl 0.0013637542724609375
amm 0.00586700439453125
ation 7.295608520507812e-05
. 1.0087890625
<0x0A> 0.44873046875
In 2.00390625
▁conclusion 0.66943359375
, 0.00027942657470703125
▁chron 0.73046875
ic 0.004070281982421875
▁infl 0.0010004043579101562
amm 0.0011911392211914062
ation 4.982948303222656e-05
▁significantly 7.58984375
▁impact 2.09375
s 0.0005102157592773438
▁individuals 2.951171875
▁with 0.04486083984375
▁end 0.64306640625
- 0.003818511962890625
stage 0.0013027191162109375
▁ren 0.0100555419921875
al 7.62939453125e-06
▁disease 1.1328125
▁and 1.9140625
▁those 7.76953125
▁under 0.274658203125
going 0.0012950897216796875
▁d 0.2369384765625
ial 3.337860107421875e-06
ysis 0.001094818115234375
. 0.72216796875
▁The 1.2880859375
▁article 0.89892578125
▁sh 3.4296875
eds 0.0016460418701171875
▁light 0.003124237060546875
▁on 0.00044846534729003906
▁the 0.09881591796875
▁leading 0.236083984375
▁causes 0.01531982421875
▁of 0.068115234375
▁chron 0.1409912109375
ic 0.00011837482452392578
▁infl 0.0002472400665283203
amm 0.0004565715789794922
ation 3.0279159545898438e-05
, 1.580078125
▁emphas 6.45703125
izing 0.264892578125
▁the 0.203857421875
▁role 2.4609375
▁of 0.1416015625
▁middle 0.12164306640625
▁mole 0.0014677047729492188
cules 0.0023593902587890625
▁and 2.591796875
▁ox 3.02734375
id 7.939338684082031e-05
ative 0.001483917236328125
▁stress 0.0025634765625
. 3.908203125
▁It 1.4794921875
▁also 0.5595703125
▁highlight 0.298095703125
s 0.0007987022399902344
▁the 0.3759765625
▁det 7.9453125
r 0.0083770751953125
iment 0.00014412403106689453
al 4.649162292480469e-05
▁effects 0.86962890625
▁of 0.09796142578125
▁chron 0.099365234375
ic 0.00014388561248779297
▁infl 0.0007004737854003906
amm 0.00200653076171875
ation 1.800060272216797e-05
▁on 0.45263671875
▁clin 0.31689453125
ical 0.000148773193359375
▁out 0.01120758056640625
comes 1.0251998901367188e-05
▁and 0.86279296875
▁the 1.27734375
▁development 2.34765625
▁of 0.0022296905517578125
▁d 1.9423828125
ial 0.0004940032958984375
ysis 0.002918243408203125
- 0.0125732421875
related 0.0192718505859375
▁am 0.0302276611328125
y 0.00016510486602783203
lo 0.00017309188842773438
idos 0.00774383544921875
is 0.0017423629760742188
. 0.1959228515625
▁However 4.11328125
, 0.0005621910095214844
▁recent 0.0628662109375
▁break 0.282470703125
through 0.00011396408081054688
s 0.0010328292846679688
▁and 0.12158203125
▁research 0.00885772705078125
▁in 0.1849365234375
▁d 0.013214111328125
ial 4.410743713378906e-06
ysis 0.00034546852111816406
▁offer 5.31640625
▁hope 0.65234375
▁for 0.278076171875
▁stabil 4.2421875
izing 0.2249755859375
▁the 1.427734375
▁condition 0.06475830078125
. 3.859375
▁Effect 9.015625
ive 0.02813720703125
▁removal 7.44140625
▁of 0.0169219970703125
▁middle 0.031951904296875
▁mole 0.0003590583801269531
cules 0.0017795562744140625
▁and 1.583984375
▁adv 5.89453125
ances 0.1639404296875
▁in 0.0003752708435058594
▁technology 4.984375
▁have 1.1318359375
▁the 3.484375
▁potential 0.01763916015625
▁to 0.0028095245361328125
▁reduce 1.2666015625
▁chron 0.3935546875
ic 9.489059448242188e-05
▁infl 0.00020623207092285156
amm 0.00146484375
ation 5.936622619628906e-05
▁and 0.44189453125
▁improve 0.156982421875
▁clin 0.1588134765625
ical 7.68899917602539e-05
▁out 0.00545501708984375
comes 4.220008850097656e-05
▁in 0.4619140625
▁individuals 1.0078125
▁with 0.039581298828125
▁E 0.3369140625
SR 0.00014150142669677734
D 0.0004355907440185547
. 0.25146484375
